Literature DB >> 12750252

BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.

Anneke C Blackburn1, Jennifer S Brown, Stephen P Naber, Christopher N Otis, Jeff T Wood, D Joseph Jerry.   

Abstract

In mice heterozygous for p53 (Trp53(+/-)), the incidence of mammary tumors varies among strains, with C57BL/6 being resistant and BALB/c being susceptible. Mammary tumor phenotypes were examined in female Trp53(+/-) F1 mice (C57BL/6 x BALB/c;n = 19) and N2 backcross mice [(C57BL/6 x BALB/c) x BALB/c] (n = 224). Susceptibility to mammary tumors segregated as a dominant phenotype in F1 females, but a higher frequency and shorter latency in N2 mice indicated a contribution from recessive-acting modifiers. Segregation of the hypomorphic BALB/c alleles for DNA-dependent protein kinase catalytic subunit (Prkdc) and p16(INK4A) (Cdkn2a) was analyzed in the N2 mice. The time to first tumor (considering all tumor types) was significantly different among the four genotype combinations (P = 0.01). Cdkn2a had a strong effect (P = 0.008) but was restricted to Prkdc(B/B) mice (P = 0.001), indicating a strong interaction between the loci. Differences in mammary tumor occurrence among genotypes for Prkdc and Cdkn2a in N2 mice were not statistically significant. This study indicates that BALB/c Prkdc and Cdkn2a alleles do modify tumor incidence in Trp53(+/-) mice and highlights the complexity of gene interaction effects in determining cancer phenotypes but discounts these alleles as major recessive loci contributing to spontaneous mammary tumor susceptibility.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750252

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.

Authors:  Anneke C Blackburn; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-08       Impact factor: 2.673

2.  Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss.

Authors:  T A Rose-Hellekant; M D Schroeder; J L Brockman; O Zhdankin; R Bolstad; K S Chen; M N Gould; L A Schuler; E P Sandgren
Journal:  Oncogene       Date:  2007-03-05       Impact factor: 9.867

Review 3.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

4.  Contrasting epistatic interactions between rat quantitative trait loci controlling mammary cancer development.

Authors:  Géraldine Piessevaux; Virginie Lella; Michèle Rivière; Daniel Stieber; Pierre Drèze; Josiane Szpirer; Claude Szpirer
Journal:  Mamm Genome       Date:  2008-12-04       Impact factor: 2.957

5.  Mammary tumor modifiers in BALB/cJ mice heterozygous for p53.

Authors:  Joanna G Koch; Xiangjun Gu; Younghun Han; Adel K El-Naggar; Melissa V Olson; Daniel Medina; D Joseph Jerry; Anneke C Blackburn; Gary Peltz; Christopher I Amos; Guillermina Lozano
Journal:  Mamm Genome       Date:  2007-06-08       Impact factor: 2.957

6.  Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.

Authors:  Chun-Ming Chen; Richard R Behringer
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

7.  Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.

Authors:  Anneke C Blackburn; Linda Z Hill; Amy L Roberts; Jun Wang; Dee Aud; Jimmy Jung; Tania Nikolcheva; John Allard; Gary Peltz; Christopher N Otis; Qing J Cao; Reva St J Ricketts; Stephen P Naber; Jan Mollenhauer; Annemarie Poustka; Daniel Malamud; D Joseph Jerry
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

8.  Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.

Authors:  Pengju Zhang; Alvin Lo; Yurong Huang; Ge Huang; Guozhou Liang; Joni Mott; Gary H Karpen; Eleanor A Blakely; Mina J Bissell; Mary Helen Barcellos-Hoff; Antoine M Snijders; Jian-Hua Mao
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

9.  siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Authors:  M Böhringer; K Obermeier; N Griner; D Waldraff; E Dickinson; K Eirich; D Schindler; M Hagen; D J Jerry; L Wiesmüller
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

Review 10.  HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis.

Authors:  Mary Helen Barcellos-Hoff; Jian-Hua Mao
Journal:  Front Oncol       Date:  2016-03-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.